Analgesics
Antiandrogens
Antihistamines
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
PPIs
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Abstract
All quercetin studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19early.org COVID-19 treatment researchQuercetinQuercetin (more..)
Melatonin Meta
Metformin Meta
Antihistamines Meta
Azvudine Meta Molnupiravir Meta
Bromhexine Meta
Budesonide Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta PPIs Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis       

Antiviral Significance of Isoquercetin (Quercetin-3-O-Glucoside) With Special Reference to its Anti-Coronaviral Potential

Agrawal et al., Natural Product Communications, doi:10.1177/1934578X231219560
Jan 2024  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
Quercetin for COVID-19
24th treatment shown to reduce risk in July 2021, now with p = 0.0031 from 11 studies.
No treatment is 100% effective. Protocols combine treatments.
5,100+ studies for 109 treatments. c19early.org
Review of the broad-spectrum antiviral significance of isoquercetin (quercetin-3-O-glucoside), focusing on SARS-CoV-2. Authors describe evidence from many studies showing inhibitory effects of isoquercetin on several stages of the viral life cycle, including blocking virus entry, interfering with replication, and preventing virus release. Through molecular docking studies, isoquercetin is predicted to bind viral proteins like the main protease (Mpro) and spike protein. Authors recommend further investigation of isoquercetin for SARS-CoV-2 due its multi-targeted binding and inhibitory effects on viral processes combined with ancillary antioxidant, anti-inflammatory, and anticoagulant properties.
Bioavailability. Quercetin has low bioavailability and studies typically use advanced formulations to improve bioavailability which may be required to reach therapeutic concentrations.
Reviews covering quercetin for COVID-19 include1-18.
Agrawal et al., 9 Jan 2024, peer-reviewed, 3 authors. Contact: agrawal@naturalproduct.us.
This PaperQuercetinAll
Antiviral Significance of Isoquercetin (Quercetin-3-O-Glucoside) With Special Reference to its Anti-Coronaviral Potential
Pawan K Agrawal, Gerald Blunden, Claus Jacob
Natural Product Communications, doi:10.1177/1934578x231219560
Isoquercetin, a naturally occurring dietary flavonoid glycoside, has shown many promising biological activities, such as antioxidant, anti-inflammatory, and anticancer. It also exhibits broad-spectrum antiviral activity, significantly reducing cell infection by influenza, Zika, Ebola, and dengue viruses, among others. Its beneficial effect for mitigating the disease of COVID-19 can be explained due to its inhibitory effects on several stages of the viral life cycle, from entry to replication and virus infectivity, and thus isoquercetin can be a promising anticoronaviral flavonoid to manage severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection and warrants further investigation into its potential use in clinical settings.
Declaration of Conflicting Interests The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
References
Agrawal, Agrawal, Blunden, Antiviral and possible prophylactic significance of myricetin for COVID 19, Nat Prod Commun, doi:10.1177/1934578X231166283.
Agrawal, Agrawal, Blunden, Naringenin as a possible candidate against SARS-CoV-2 infection and in the pathogenesis of COVID-19, Nat Prod Commun, doi:10.1177/1934578X211066723.
Agrawal, Agrawal, Blunden, Pharmacological significance of hesperidin and hesperetin, two citrus flavonoids, as promising antiviral compounds for prophylaxis against and combating COVID-19, Nat Prod Commun, doi:10.1177/1934578X211042540.
Agrawal, Agrawal, Blunden, Quercetin: antiviral significance and possible COVID-19 integrative considerations, Nat Prod Commun, doi:10.1177/1934578X20976293
Agrawal, Agrawal, Blunden, Rutin: a potential antiviral for repurposing as a SARS-CoV-2 main protease (M pro ) inhibitor, Nat Prod Commun, doi:10.1177/1934578X21991723.
Aguilar, Báez, Galeano, Oral quercetin in adult patients as a potential nutraceutical against coronavirus disease 2019 (COVID-19), J Adv Med Pharm Sci, doi:10.9734/JAMPS/2021/v23i330222.
Albeshri, Baeshen, Bouback, Evaluation of cytotoxicity and antiviral activity of Rhazya stricta Decne leaves extract against influenza A/PR/8/34 (H1N1), Saudi J Biol Sci, doi:10.1016/j.sjbs.2022.103375
Augustin, Hajbabaie, Harper, Novel smallmolecule scaffolds as candidates against the SARS coronavirus 2 main protease: a fragment-guided in silico approach, Molecules, doi:10.3390/molecules25235501.
Badshah, Faisal, Muhammad, Antiviral activities of flavonoids, Biomed Pharmacother, doi:10.1016/j.biopha.2021.111596.
Bellavite, Reappraisal of dietary phytochemicals for coronavirus infection: Focus on hesperidin and quercetin, Antioxidants. Intechopen, doi:10.5772/intechopen.95529
Berardini, Fezer, Conrad, Screening of mango (Mangifera indica L.) cultivars for their contents of flavonol Oand xanthone C-glycosides, anthocyanins, and pectin, J Agric Food Chem, doi:10.1021/jf0484069
Bhat, Bhat, Quercetin: a bioactive compound imparting cardiovascular and neuroprotective benefits: scope for exploring fresh produce, their wastes, and by-products, Biology, doi:10.3390/biology10070586.
Bondonno, Bondonno, Ward, Enzymatically modified isoquercitrin improves endothelial function in volunteers at risk of cardiovascular disease, Br J Nutr, doi:10.1017/S0007114519002137.
Brito, Lima, Da, Nizer, Quercetin as a potential nutraceutic against coronavirus disease 2019 (COVID-19) / La Quercetina como un potencial nutracéutico contra la enfermedad por coronavirus 2019 (COVID-19), Ars Pharm
Buonerba, Placido, Bruzzese, Isoquercetin as an adjunct therapy in patients with kidney cancer receiving first-line sunitinib (QUASAR): results of a phase I trial, Front Pharmacol, doi:10.3389/fphar.2018.00189.
Chang, Wong, Identification of flavonoids in Hakmeitau beans (Vigna sinensis) by high-performance liquid chromatographyelectrospray mass spectrometry (LC-ESI/MS), J Agric Food Chem, doi:10.1021/jf049114a
Chen, Feng, Peng, Protective effects of isoquercitrin on streptozotocin-induced neurotoxicity, J Cell Mol Med, doi:10.1111/jcmm.15658.
Chen, Wang, Yang, Houttuynia cordata blocks HSV infection through inhibition of NF-κB activation, Antiviral Res, doi:10.1016/j.antiviral.2011.09.005
Cho, Lee, Ma, Antiviral effect of isoquercitrin against influenza A viral infection via modulating hemagglutinin and neuraminidase, Int J Mol Sci, doi:10.3390/ijms232113112.
Cho, Yang, Ma, Lotus (Nelumbo nucifera Gaertn.) leaf water extracts suppress influenza a viral infection via inhibition of neuraminidase and hemagglutinin, J Funct Foods, doi:10.1016/j.jff.2022.105019
Choi, Antiviral activity of quercetin-3-glucoside against nonpolio enterovirus, J Bacteriol Virol, doi:10.4167/jbv.2022.52.1.020.
Da Silva, Orfali, Santana, Antitumor effect of isoquercetin on tissue vasohibin expression and colon cancer vasculature, Oncotarget, doi:10.18632/oncotarget.28181.
Dai, Zhang, Zhang, Isoquercetin attenuates oxidative stress and neuronal apoptosis after ischemia/reperfusion injury via Nrf2-mediated inhibition of the NOX4/ROS/NF-κB pathway, Chem Biol Interact, doi:10.1016/j.cbi.2018.02.017.
Derosa, Maffioli, Angelo, A role for quercetin in coronavirus disease 2019 (COVID-19), Phytother Res, doi:10.1002/ptr.6887.
Djuricic, Ciric, Vidovic, Nutraceuticals in prevention and management of COVID-19, Hrana I Ishrana, doi:10.5937/hraIsh2102007D.
Dos Santos, Kuster, Yamamoto, Quercetin and quercetin 3-O-glycosides from Bauhinia longifolia (Bong.) Steud. Show anti-Mayaro virus activity, Parasites Vectors, doi:10.1186/1756-3305-7-130
Farabi, Saha, Hasanuzzaman, Prediction of SARS-CoV-2 main protease inhibitors in medicinal plant derived compounds by molecular docking approach, J Adv Biotechnol Exp Ther, doi:10.5455/jabet.2020.d159.
Fazio, Affuso, Bellavite, A review of the potential roles of antioxidant and anti-inflammatory pharmacological approaches for the management of mild-to-moderate symptomatic COVID-19, Med Sci Monit, doi:10.12659/MSM.936292.
Fredsgaard, Kaniki, Antonopoulou, Phenolic compounds in Salicornia spp. and their potential therapeutic effects on H1N1, HBV, HCV, and HIV: a review, Molecules, doi:10.3390/molecules28145312
Gasmi, Mujawdiya, Lysiuk, Quercetin in the prevention and treatment of coronavirus infections: a focus on SARS-CoV-2, Pharmaceuticals, doi:10.3390/ph15091049.
Gaudry, Bos, Viranaicken, The flavonoid isoquercitrin precludes initiation of Zika virus infection in human cells, Int J Mol Sci, doi:10.3390/ijms19041093.
Godinho, Soengas, Silva, Therapeutic potential of glycosyl flavonoids as anti-coronaviral agents, Pharmaceuticals, doi:10.3390/ph14060546.
Gonzales, Camp, Zotti, Two-and threedimensional quantitative structure-permeability relationship of flavonoids in caco-2 cells using stepwise multiple linear regression (SMLR), partial least squares regression (PLSR), and pharmacophore (GALAHAD)-based comparative molecular similarity index analysis (COMSIA), Med Chem Res, doi:10.1007/s00044-014-1241-4.
Gu, Zhang, Cen, Quercetin as a potential treatment for COVID-19-induced acute kidney injury: based on network pharmacology and molecular docking study, PLoS One, doi:10.1371/journal.pone.0245209.
Hiremath, Kumar, Nandan, In silico docking analysis revealed the potential of phytochemicals present in Phyllanthus amarus and Andrographis paniculata, used in ayurveda medicine in inhibiting SARS-CoV-2, 3 Biotech, doi:10.1007/s13205-020-02578-7
Hobbs, Koyanagi, Swartz, Comprehensive evaluation of the flavonol anti-oxidants, alpha-glycosyl isoquercitrin and isoquercitrin, for genotoxic potential, Food Chem Toxicol, doi:10.1016/j.fct.2017.12.059.
Hoffmann, Kleine-Weber, Schroeder, SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor, Cell, doi:10.1016/j.cell.2020.02.052
Hung, Ho, Lee, Houttuynia cordata targets the beginning stage of Herpes Simplex Virus infection, PLoS ONE, doi:10.1371/journal.pone.0115475
Imran, Thabet, Alaqel, The therapeutic and prophylactic potential of quercetin against COVID-19: an outlook on the clinical studies, inventive compositions, and patent literature, Antioxidants, doi:10.3390/antiox11050876.
Ionescu, An overview of the crystallized structures of the SARS-CoV-2, Protein J, doi:10.1007/s10930-020-09933-w
Istifli, Netz, Tepe, In silico analysis of the interactions of certain flavonoids with the receptor-binding domain of 2019 novel coronavirus and cellular proteases and their pharmacokinetic properties, J Biomol Struct Dynam, doi:10.1080/07391102.2020.1840444
Jarerattanachat, Boonarkart, Hannongbua, In silico and in vitro studies of potential inhibitors against dengue viral protein NS5 methyl transferase from Ginseng and Notoginseng, J Tradit Complement Med, doi:10.1016/j.jtcme.2022.12.002
Jayachandran, Wu, Ganesan, Isoquercetin upregulates antioxidant genes, suppresses inflammatory cytokines and regulates AMPK pathway in streptozotocin-induced diabetic rats, Chem Biol Interact, doi:10.1016/j.cbi.2019.02.017.
Jayachandran, Zhang, Wu, Isoquercetin regulates SREBP-1C via AMPK pathway in skeletal muscle to exert antihyperlipidemic and anti-inflammatory effects in STZ induced diabetic rats, Mol Biol Rep, doi:10.1007/s11033-019-05166-y.
Jo, Kim, Kim, Characteristics of flavonoids as potent MERS-CoV 3C-like protease inhibitors, Chem Biol Drug Des, doi:10.1111/cbdd.13604.
Johnson, Adegboyega, Ojo, A computational approach to elucidate the interactions of chemicals from Artemisia annua targeted toward SARS-CoV-2 main protease inhibition for COVID-19 treatment, Front Med, doi:10.3389/fmed.2022.907583
Joshi, Jagdale, Bansode, Discovery of potential multi-target-directed ligands by targeting host-specific SARS-CoV-2 structurally conserved main protease, J Biomol Struct Dyn, doi:10.1080/07391102.2020.1760137.
Kashyap, Thakur, Singh, In silico evaluation of natural flavonoids as a potential inhibitor of coronavirus disease, Molecules, doi:10.3390/molecules27196374
Khan, Iqtadar, Mumtaz, Oral co-supplementation of curcumin, quercetin, and vitamin D3 as an adjuvant therapy for mild to moderate symptoms of COVID-19-results from a pilot open-label, randomized controlled trial, Front Pharmacol, doi:10.3389/fphar.2022.898062.
Kim, Chun, Kim, Quantification of polyphenolics and their antioxidant capacity in fresh plums, J Agric Food Chem, doi:10.1021/jf0343074
Kim, Kim, Song, Antiviral activities of quercetin and isoquercitrin against human herpesviruses, Molecules, doi:10.3390/molecules25102379.
Kim, Narayanan, Ko, Inhibition of influenza virus replication by plant-derived isoquercetin, Antivir Res, doi:10.1016/j.antiviral.2010.08.016.
Kim, Park, Quercetin and its role in biological functions: an updated review, EXCLI J, doi:10.17179/excli2018-1538
Kushwaha, Singh, Bansal, Identification of natural inhibitors against SARS-CoV-2 druggable targets using molecular docking, molecular dynamics simulation, and MM-PBSA approach, Front Cell Infect Microbiol, doi:10.3389/fcimb.2021.730288.
Kwak, Seo, Kim, Variation of quercetin glycoside derivatives in three onion (Allium cepa L.) varieties, Saudi J Biol Sci, doi:10.1016/j.sjbs.2016.05.014
Lalani, Poh, Flavonoids as antiviral agents for enterovirus A71 (EV-A71), Viruses, doi:10.3390/v12020184.
Levy, Delvin, Marcil, Can phytotherapy with polyphenols serve as a powerful approach for the prevention and therapy tool of novel coronavirus disease 2019 (COVID-19)?, Am J Physiol Endocrinol Metab, doi:10.1152/ajpendo.00298.2020.
Liu, Raghuvanshi, Ceylan, Quercetin and its metabolites inhibit recombinant human angiotensin-converting enzyme 2 (ACE2) activity, J Agric Food Chem, doi:10.1021/acs.jafc.0c05064.
Ma, Li, Yang, Isoquercitrin attenuates steatohepatitis by inhibition of the activated NLRP3 inflammasome through HSP90, Int J Mol Sci, doi:10.3390/ijms24108795.
Makino, Shimizu, Kanemaru, Enzymatically modified isoquercitrin, alpha-oligoglucosyl quercetin 3-O-glucoside is absorbed more easily than other quercetin glycosides or aglycone after oral administration in rats, Biol Pharm Bull, doi:10.1248/bpb.32.2034
Malaterre, Boumendjel, Seteyen, Focus on the high therapeutic potentials of quercetin and its derivatives, Phytomed Plus, doi:10.1016/j.phyplu.2022.100220.
Manjunath, Thimmulappa, Antiviral, immunomodulatory, and anticoagulant effects of quercetin and its derivatives: potential role in prevention and management of COVID-19, J Pharmaceutical Anal, doi:10.1016/j.jpha.2021.09.009.
Mazik, Promising therapeutic approach for SARS-CoV-2 infections by using a rutin-based combination therapy, ChemMedChem, doi:10.1002/cmdc.202200157.
Mbikay, Chrétien, Isoquercetin as an anti-COVID-19 medication: a potential to realize, Front Pharmacol, doi:10.3389/fphar.2022.830205.
Mouffouk, Mouffouk, Mouffouk, Flavonols as potential antiviral drugs targeting SARS-CoV-2 proteases (3CL pro and PL pro ), spike protein, RNA-dependent RNA polymerase (RdRp) and angiotensin-converting enzyme II receptor (ACE2), Eur J Pharmacol, doi:10.1016/j.ejphar.2020.173759
Nair, James, Computational screening of phytocompounds from Moringa oleifera leaf as potential inhibitors of SARS-CoV-2 Mpro, Res Square, doi:10.21203/rs.3.rs-71018/v1
Nile, Kim, Nile, Probing the effect of quercetin 3-glucoside from Dianthus superbus L against influenza virus infection-in vitro and in silico biochemical and toxicological screening, Food Chem Toxicol, doi:10.1016/j.fct.2019.110985
Ohguchi, Nakajima, Oyama, Inhibitory effects of flavonoid glycosides isolated from the peel of Japanese persimmon (Diospyros kaki 'Fuyu') on melanin biosynthesis, Biol Pharm Bull, doi:10.1248/bpb.33.122
Palghadmal, Kulkarni, Makadia, Tackling complications of coronavirus infection with quercetin: observations and hypotheses, Explor Res Hypothesis Med, doi:10.14218/ERHM.2021.00015.
Parihar, Sonia, Akter, Phytochemicals-based targeting RdRp and main protease of SARS-CoV-2 using docking and steered molecular dynamic simulation: a promising therapeutic approach for tackling COVID-19, Comput Biol Med, doi:10.1016/j.compbiomed.2022.105468.
Paul, Jahan, Bondhon, Potential role of flavonoids against SARS-CoV-2 induced diarrhea, Trop Biomed, doi:10.47665/tb.38.3.079.
Pawar, Russo, Rani, A critical evaluation of risk to reward ratio of quercetin supplementation for COVID-19 and associated comorbid conditions, Phytother Res, doi:10.1002/ptr.7461.
Peterson, COVID-19 and flavonoids: in silico molecular dynamics docking to the active catalytic site of SARS-CoV and SARS-CoV-2 main protease
Petrillo, Orrù, Fais, Quercetin and its derivates as antiviral potentials: a comprehensive review, Phytother Res, doi:10.1002/ptr.7309.
Qiu, Kroeker, He, Prophylactic efficacy of quercetin 3-β-O-D-glucoside against Ebola virus infection, Antimicrob Agents Chemother, doi:10.1128/AAC.00307-16
Qiu, Yang, Wang, Isoquercitrin promotes peripheral nerve regeneration through inhibiting oxidative stress following sciatic crush injury in mice, Ann Transl Med, doi:10.21037/atm.2019.11.18.
Quecan, Santos, Rivera, Effect of quercetin rich onion extracts on bacterial quorum sensing, Front Microbiol, doi:10.3389/fmicb.2019.00867
Rabezanahary, Badr, Checkmahomed, Epigallocatechin gallate and isoquercetin synergize with Remdesivir to reduce SARS-CoV-2 replication in vitro, Front Virol, doi:10.3389/fviro.2022.956113.
Reinboth, Wolffram, Abraham, Oral bioavailability of quercetin from different quercetin glycosides in dogs, Br J Nutr, doi:10.1017/S000711451000053X.
Saeedi-Boroujeni, Mr, Anti-inflammatory potential of quercetin in COVID-19 treatment, J Inflamm, doi:10.1186/s12950-021-00268-6.
Salehi, Machin, Monzote, Therapeutic potential of quercetin: new insights and perspectives for human health, ACS Omega, doi:10.1021/acsomega.0c01818.
Setz, Fröba, Große, European Black elderberry fruit extract inhibits replication of SARS-CoV-2 in vitro, Nutraceuticals, doi:10.3390/nutraceuticals3010007
Shi, Chen, Liu, Isoquercetin improves inflammatory response in rats following ischemic stroke, Front Neurosci, doi:10.3389/fnins.2021.555543.
Shohan, Nashibi, Mr, The therapeutic efficacy of quercetin in combination with antiviral drugs in hospitalized COVID-19 patients: a randomized controlled trial, Eur J Pharmacol, doi:10.1016/j.ejphar.2021.174615.
Shorobi, Nisa, Saha, Quercetin: a functional foodflavonoid incredibly attenuates emerging and re-emerging viral infections through immunomodulatory actions, Molecules, doi:10.3390/molecules28030938
Sony, Suresh, Molecular docking-based screening of natural heterocyclic compounds as a potential drug for COVID-19, The Open Medicinal Chem J, doi:10.2174/18741045-v17-230619-2023-7.
Suárez, Álvarez, García, Phenolic profiles, antioxidant activity and in vitro antiviral properties of apple pomace, Food Chem, doi:10.1016/j.foodchem.2009.09.073
Tabari, Iranpanah, Bahramsoltani, Flavonoids as promising antiviral agents against SARS-CoV-2 infection: a mechanistic review, Molecules, doi:10.3390/molecules261339.
Tan, Caparros-Martin, Matthews, Isoquercetin and inulin synergistically modulate the gut microbiome to prevent development of the metabolic syndrome in mice fed a high fat diet, Sci Rep, doi:10.1038/s41598-018-28521-8.
Us Fda, Agency response letter GRAS notice no
Valentová, Vrba, Bancířová, Isoquercitrin: pharmacology, toxicology, and metabolism, Food Chem Toxicol, doi:10.1016/j.fct.2014.03.018.
Wang, Song, Liu, Research progress of the antiviral bioactivities of natural flavonoids, Nat Prod Bioprospect, doi:10.1007/s13659-020-00257-x.
Wang, Wang, Yao, Pharmacological activity of quercetin: an updated review, Evid-Based Complement Altern Med, doi:10.1155/2022/3997190.
Wong, He, Siragam, Antiviral activity of quercetin-3-β-O-D-glucoside against Zika virus infection, Virol Sin, doi:10.1007/s12250-017-4057-9
Wrapp, Wang, Corbett, Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation, Science, doi:10.1126/science.abb2507
Wurtele, Coelho, Gallo, Inhibition of the SARS-CoV-2 main protease by isoquercitrin γ-cyclodextrin inclusion complex formulations: a biochemical and in silico study, J Chem, doi:10.1155/2023/4586423
Xia, Zhong, Li, Antioxidant and anti-fatigue constituents of okra, Nutrients, doi:10.3390/nu7105435.
Yao, Zhang, Wang, Flavonoids for treating viral acute respiratory tract infections: a systematic review and meta-analysis of 30 randomized controlled trials, Front Public Health, doi:10.3389/fpubh.2022.814669.
Ye, Luo, Ye, Network pharmacology, molecular docking integrated surface plasmon resonance technology reveals the mechanism of Toujie Quwen granules against coronavirus disease 2019 pneumonia, Phytomedicine, doi:10.1016/j.phymed.2020.153401.
Yun, Woo, Lee, Effect of isoquercitrin on membrane dynamics and apoptosis-like death in Escherichia coli, Biochim Biophys Acta Biomembr, doi:10.1016/j.bbamem.2017.11.008.
Zaragoza, Villaescusa, Monserrat, Potential therapeutic anti-inflammatory and immunomodulatory effects of dihydroflavones, flavones, and flavonols, Molecules, doi:10.3390/molecules25041017
Zarenezhad, Abdulabbas, Kareem, Protective role of flavonoids quercetin and silymarin in the viral-associated inflammatory bowel disease: an updated review, Arch Microbiol, doi:10.1007/s00203-023-03590-0.
Zhu, Li, Wang, Isoquercitrin inhibits hydrogen peroxide-induced apoptosis of EA.hy926 cells via the PI3K/ Akt/GSK3beta signaling pathway, Molecules, doi:10.3390/molecules21030356
Zhu, Scholle, Kisthardt, Flavonols and dihydroflavonols inhibit the main protease activity of SARS-CoV-2 and the replication of human coronavirus 229, E. Virology, doi:10.1016/j.virol.2022.04.005.
Zwicker, Schlechter, Stopa, Targeting protein disulfide isomerase with the flavonoid isoquercetin to improve hypercoagulability in advanced cancer, JCI Insight, doi:10.1172/jci.insight.125851.
Önal, Arslan, Ergun, Treatment of COVID-19 patients with quercetin: a prospective, single center, randomized, controlled trial, Turk J Biol, doi:10.3906/biy-2104-16.
{ 'indexed': {'date-parts': [[2024, 1, 11]], 'date-time': '2024-01-11T00:25:53Z', 'timestamp': 1704932753738}, 'reference-count': 109, 'publisher': 'SAGE Publications', 'issue': '1', 'license': [ { 'start': { 'date-parts': [[2024, 1, 1]], 'date-time': '2024-01-01T00:00:00Z', 'timestamp': 1704067200000}, 'content-version': 'unspecified', 'delay-in-days': 0, 'URL': 'https://creativecommons.org/licenses/by-nc/4.0/'}], 'content-domain': {'domain': ['journals.sagepub.com'], 'crossmark-restriction': True}, 'published-print': {'date-parts': [[2024, 1]]}, 'abstract': '<jats:p> Isoquercetin, a naturally occurring dietary flavonoid glycoside, has shown many ' 'promising biological activities, such as antioxidant, anti-inflammatory, and anticancer. It ' 'also exhibits broad-spectrum antiviral activity, significantly reducing cell infection by ' 'influenza, Zika, Ebola, and dengue viruses, among others. Its beneficial effect for ' 'mitigating the disease of COVID-19 can be explained due to its inhibitory effects on several ' 'stages of the viral life cycle, from entry to replication and virus infectivity, and thus ' 'isoquercetin can be a promising anticoronaviral flavonoid to manage severe acute respiratory ' 'syndrome-coronavirus-2 (SARS-CoV-2) infection and warrants further investigation into its ' 'potential use in clinical settings. </jats:p>', 'DOI': '10.1177/1934578x231219560', 'type': 'journal-article', 'created': {'date-parts': [[2024, 1, 10]], 'date-time': '2024-01-10T07:49:35Z', 'timestamp': 1704872975000}, 'update-policy': 'http://dx.doi.org/10.1177/sage-journals-update-policy', 'source': 'Crossref', 'is-referenced-by-count': 0, 'title': 'Antiviral Significance of Isoquercetin (Quercetin-3-<i>O</i>-Glucoside) With Special Reference ' 'to its Anti-Coronaviral Potential', 'prefix': '10.1177', 'volume': '19', 'author': [ { 'given': 'Pawan K', 'family': 'Agrawal', 'sequence': 'first', 'affiliation': [{'name': 'Natural Product Inc., Westerville, OH, USA'}]}, { 'given': 'Gerald', 'family': 'Blunden', 'sequence': 'additional', 'affiliation': [ { 'name': 'School of Pharmacy and Biomedical Science, University of ' 'Portsmouth, Portsmouth, UK'}]}, { 'given': 'Claus', 'family': 'Jacob', 'sequence': 'additional', 'affiliation': [ { 'name': 'Division of Bioorganic Chemistry, School of Pharmacy, Saarland ' 'University, Saarbrucken, Germany'}]}], 'member': '179', 'published-online': {'date-parts': [[2024, 1, 9]]}, 'reference': [ { 'key': 'bibr1-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.1021/jf0343074'}, { 'key': 'bibr2-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.1021/jf049114a'}, { 'key': 'bibr3-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.1021/jf0484069'}, { 'key': 'bibr4-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.foodchem.2009.09.073'}, { 'key': 'bibr5-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.sjbs.2016.05.014'}, { 'key': 'bibr6-1934578X231219560', 'first-page': '856', 'volume': '17', 'author': 'Kim JK', 'year': '2018', 'journal-title': 'EXCLI J'}, { 'issue': '12', 'key': 'bibr7-1934578X231219560', 'first-page': '1', 'volume': '15', 'author': 'Agrawal PK', 'year': '2020', 'journal-title': 'Nat Prod Commun'}, { 'key': 'bibr8-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.1021/acsomega.0c01818'}, { 'key': 'bibr9-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.3390/biology10070586'}, { 'issue': '4', 'key': 'bibr10-1934578X231219560', 'first-page': '1', 'volume': '16', 'author': 'Agrawal PK', 'year': '2021', 'journal-title': 'Nat Prod Commun'}, { 'issue': '1', 'key': 'bibr11-1934578X231219560', 'first-page': '85', 'volume': '62', 'author': 'Brito JCM', 'year': '2021', 'journal-title': 'Ars Pharm'}, { 'key': 'bibr12-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.3390/ph15091049'}, { 'key': 'bibr13-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.jpha.2021.09.009'}, { 'key': 'bibr14-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.1002/cmdc.202200157'}, { 'key': 'bibr15-1934578X231219560', 'volume-title': 'Antioxidants', 'author': 'Bellavite P', 'year': '2021'}, { 'key': 'bibr16-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.ejphar.2021.174615'}, { 'key': 'bibr17-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.1007/s00044-014-1241-4'}, { 'key': 'bibr18-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.3389/fmicb.2019.00867'}, { 'key': 'bibr19-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.1248/bpb.33.122'}, { 'key': 'bibr20-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.fct.2014.03.018'}, { 'key': 'bibr21-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.3390/nu7105435'}, { 'key': 'bibr22-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.bbamem.2017.11.008'}, { 'key': 'bibr23-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.cbi.2018.02.017'}, { 'key': 'bibr24-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.21037/atm.2019.11.18'}, { 'key': 'bibr25-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.cbi.2019.02.017'}, { 'key': 'bibr26-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.3390/molecules21030356'}, { 'key': 'bibr27-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.1017/S0007114519002137'}, { 'key': 'bibr28-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.1007/s11033-019-05166-y'}, { 'key': 'bibr29-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.1111/jcmm.15658'}, { 'key': 'bibr30-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.3389/fnins.2021.555543'}, { 'key': 'bibr31-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.fct.2017.12.059'}, { 'key': 'bibr32-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.1038/s41598-018-28521-8'}, { 'key': 'bibr33-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.18632/oncotarget.28181'}, { 'key': 'bibr34-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.3390/ijms24108795'}, { 'key': 'bibr35-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.3389/fphar.2022.830205'}, { 'key': 'bibr36-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.3389/fphar.2018.00189'}, { 'key': 'bibr37-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.1172/jci.insight.125851'}, { 'key': 'bibr38-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.3390/v12020184'}, { 'key': 'bibr39-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.1152/ajpendo.00298.2020'}, { 'key': 'bibr40-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.1007/s13659-020-00257-x'}, { 'issue': '10', 'key': 'bibr41-1934578X231219560', 'first-page': '1', 'volume': '16', 'author': 'Agrawal PK', 'year': '2021', 'journal-title': 'Nat Prod Commun'}, { 'issue': '12', 'key': 'bibr42-1934578X231219560', 'first-page': '1', 'volume': '16', 'author': 'Agrawal PK', 'year': '2021', 'journal-title': 'Nat Prod Commun'}, { 'key': 'bibr43-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.biopha.2021.111596'}, { 'key': 'bibr44-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.3390/ph14060546'}, { 'key': 'bibr45-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.3390/molecules26133900'}, { 'issue': '3', 'key': 'bibr46-1934578X231219560', 'first-page': '1', 'volume': '23', 'author': 'Aguilar JFI', 'year': '2021', 'journal-title': 'J Adv Med Pharm Sci'}, { 'key': 'bibr47-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.1002/ptr.6887'}, { 'key': 'bibr48-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.3906/biy-2104-16'}, { 'key': 'bibr49-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.1186/s12950-021-00268-6'}, { 'key': 'bibr50-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.5937/hraIsh2102007D'}, { 'key': 'bibr51-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.3390/antiox11050876'}, { 'key': 'bibr52-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.3389/fphar.2022.898062'}, { 'key': 'bibr53-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.12659/MSM.936292'}, { 'issue': '4', 'key': 'bibr54-1934578X231219560', 'first-page': '1', 'volume': '18', 'author': 'Agrawal PK', 'year': '2023', 'journal-title': 'Nat Prod Commun'}, { 'issue': '4', 'key': 'bibr55-1934578X231219560', 'first-page': '193', 'volume': '6', 'author': 'Palghadmal SB', 'year': '2021', 'journal-title': 'Explor Res Hypothesis Med'}, { 'key': 'bibr56-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.1002/ptr.7461'}, { 'key': 'bibr57-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.1371/journal.pone.0245209'}, { 'key': 'bibr58-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.ejphar.2020.173759'}, { 'key': 'bibr59-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.1021/acs.jafc.0c05064'}, { 'key': 'bibr60-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.phyplu.2022.100220'}, { 'key': 'bibr61-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.1002/ptr.7309'}, { 'key': 'bibr62-1934578X231219560', 'first-page': '3997190', 'author': 'Wang G', 'year': '2022', 'journal-title': 'Evid-Based Complement Altern Med'}, { 'key': 'bibr63-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.1007/s00203-023-03590-0'}, { 'key': 'bibr64-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.3390/molecules28030938'}, { 'key': 'bibr65-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.47665/tb.38.3.079'}, { 'key': 'bibr66-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.1080/07391102.2020.1840444'}, { 'issue': '9', 'key': 'bibr67-1934578X231219560', 'first-page': '3099', 'volume': '39', 'author': 'Joshi RS', 'year': '2021', 'journal-title': 'J Biomol Struct Dyn'}, { 'key': 'bibr68-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.antiviral.2011.09.005'}, { 'key': 'bibr69-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.1371/journal.pone.0115475'}, { 'key': 'bibr70-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.antiviral.2010.08.016'}, { 'key': 'bibr71-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.fct.2019.110985'}, { 'key': 'bibr72-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.jff.2022.105019'}, { 'key': 'bibr73-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.3390/ijms232113112'}, { 'key': 'bibr74-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.sjbs.2022.103375'}, { 'key': 'bibr75-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.3390/molecules28145312'}, { 'key': 'bibr76-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.1128/AAC.00307-16'}, { 'key': 'bibr77-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.3390/ijms19041093'}, { 'key': 'bibr78-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.1007/s12250-017-4057-9'}, { 'key': 'bibr79-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.1186/1756-3305-7-130'}, { 'key': 'bibr80-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.3390/molecules25102379'}, { 'key': 'bibr81-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.4167/jbv.2022.52.1.020'}, { 'key': 'bibr82-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.jtcme.2022.12.002'}, { 'key': 'bibr83-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.1126/science.abb2507'}, { 'key': 'bibr84-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.cell.2020.02.052'}, { 'key': 'bibr85-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.1007/s10930-020-09933-w'}, { 'key': 'bibr86-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.3390/molecules25235501'}, { 'key': 'bibr87-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.3390/molecules27196374'}, { 'key': 'bibr88-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.3390/molecules25041017'}, { 'key': 'bibr89-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.1111/cbdd.13604'}, { 'key': 'bibr90-1934578X231219560', 'volume-title': 'COVID-19 and flavonoids: in silico molecular dynamics docking to the ' 'active catalytic site of SARS-CoV and SARS-CoV-2 main protease', 'author': 'Peterson L', 'year': '2020'}, { 'key': 'bibr91-1934578X231219560', 'author': 'Athira Nair D', 'year': '2020', 'journal-title': 'Res Square'}, { 'key': 'bibr92-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.5455/jabet.2020.d159'}, { 'key': 'bibr93-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.2174/18741045-v17-230619-2023-7'}, { 'key': 'bibr94-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.compbiomed.2022.105468'}, { 'key': 'bibr95-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.3389/fmed.2022.907583'}, { 'key': 'bibr96-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.3389/fcimb.2021.730288'}, { 'key': 'bibr97-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.virol.2022.04.005'}, { 'key': 'bibr98-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.1007/s13205-020-02578-7'}, { 'key': 'bibr99-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.1016/j.phymed.2020.153401'}, { 'key': 'bibr100-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.3390/nutraceuticals3010007'}, { 'key': 'bibr101-1934578X231219560', 'unstructured': 'https://clinicaltrials.gov/study/NCT04733651 (accessed on September 21, ' '2023).'}, { 'key': 'bibr102-1934578X231219560', 'unstructured': 'https://clinicaltrials.gov/study/NCT04536090 (accessed on September 21, ' '2023).'}, { 'key': 'bibr103-1934578X231219560', 'unstructured': 'https://www.clinicaltrialsregister.eu/ctr-search/trial/2020-001635-27/FR ' '(accessed on September 21, 2023).'}, { 'key': 'bibr104-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.3389/fpubh.2022.814669'}, { 'key': 'bibr105-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.1248/bpb.32.2034'}, { 'key': 'bibr106-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.1155/2023/4586423'}, { 'key': 'bibr107-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.3389/fviro.2022.956113'}, { 'key': 'bibr108-1934578X231219560', 'volume-title': 'Agency response letter GRAS notice no. GRN 000341', 'author': 'US FDA', 'year': '2010'}, { 'key': 'bibr109-1934578X231219560', 'doi-asserted-by': 'publisher', 'DOI': '10.1017/S000711451000053X'}], 'container-title': 'Natural Product Communications', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'http://journals.sagepub.com/doi/pdf/10.1177/1934578X231219560', 'content-type': 'application/pdf', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'http://journals.sagepub.com/doi/full-xml/10.1177/1934578X231219560', 'content-type': 'application/xml', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'http://journals.sagepub.com/doi/pdf/10.1177/1934578X231219560', 'content-type': 'unspecified', 'content-version': 'vor', 'intended-application': 'similarity-checking'}], 'deposited': { 'date-parts': [[2024, 1, 10]], 'date-time': '2024-01-10T07:49:51Z', 'timestamp': 1704872991000}, 'score': 1, 'resource': {'primary': {'URL': 'http://journals.sagepub.com/doi/10.1177/1934578X231219560'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2024, 1]]}, 'references-count': 109, 'journal-issue': {'issue': '1', 'published-print': {'date-parts': [[2024, 1]]}}, 'alternative-id': ['10.1177/1934578X231219560'], 'URL': 'http://dx.doi.org/10.1177/1934578X231219560', 'relation': {}, 'ISSN': ['1934-578X', '1555-9475'], 'subject': [ 'Complementary and alternative medicine', 'Plant Science', 'Drug Discovery', 'Pharmacology', 'General Medicine'], 'container-title-short': 'Natural Product Communications', 'published': {'date-parts': [[2024, 1]]}}
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit